Literature DB >> 9722980

The high mobility group protein, HMGI-C.

G Goodwin1.   

Abstract

HMGI-C is a nuclear phosphoprotein that contains three short DNA-binding domains (AT-hooks) and a highly acidic C-terminus. Interest in the protein has recently been stimulated by three observations: the expression of the gene is cell-cycle regulated, the gene is rearranged in a number of tumours of mesenchymal origin and mice that have both HMGI-C alleles disrupted exhibit the pygmy phenotype. These observations suggest a role for HMGI-C in cell growth, more specifically, during foetal growth since the protein is normally only expressed in embryonic tissues. It is likely that the HMGI-C protein acts as an architectural transcription factor, regulating the expression of one or more genes that control embryonic cell growth. Since HMGI-C binds to the minor groove of AT-rich DNA this interaction could be a target for minor groove chemotherapeutic agents in the treatment of sarcomas expressing the rearranged gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722980     DOI: 10.1016/s1357-2725(98)00016-8

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  16 in total

Review 1.  Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins.

Authors:  M Bustin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity.

Authors:  M M Petit; J Fradelizi; R M Golsteyn; T A Ayoubi; B Menichi; D Louvard; W J Van de Ven; E Friederich
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

3.  Capture of AT-rich chromatin by ELYS recruits POM121 and NDC1 to initiate nuclear pore assembly.

Authors:  Beth A Rasala; Corinne Ramos; Amnon Harel; Douglass J Forbes
Journal:  Mol Biol Cell       Date:  2008-07-02       Impact factor: 4.138

Review 4.  The HMG I proteins: dynamic roles in gene activation, development, and tumorigenesis.

Authors:  F Liu; K Y Chau; P Arlotta; S J Ono
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium.

Authors:  Joëlle Dupont; Jean Pierre Renou; Moshe Shani; Lothar Hennighausen; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 6.  HMGA2 and high-grade serous ovarian carcinoma.

Authors:  Jingjing Wu; Jian-Jun Wei
Journal:  J Mol Med (Berl)       Date:  2013-05-19       Impact factor: 4.599

7.  Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation.

Authors:  Kai-Yin Chau; Guidalberto Manfioletti; Kam-Wa Cheung-Chau; Alfredo Fusco; Nathalie Dhomen; Jane C Sowden; Tetsuo Sasabe; Shizuo Mukai; Santa Jeremy Ono
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

8.  Association of a high mobility group gene (HMGA2) variant with bone mineral density.

Authors:  Allison Kuipers; Yingze Zhang; Jane A Cauley; Cara S Nestlerode; Yanxia Chu; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Andrew R Hoffman; Eric S Orwoll; Joseph M Zmuda
Journal:  Bone       Date:  2009-04-17       Impact factor: 4.398

Review 9.  Emerging roles for LPP in metastatic cancer progression.

Authors:  Elaine Ngan; Alex Kiepas; Claire M Brown; Peter M Siegel
Journal:  J Cell Commun Signal       Date:  2017-10-13       Impact factor: 5.782

10.  Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer.

Authors:  C Langelotz; P Schmid; C Jakob; U Heider; K D Wernecke; K Possinger; O Sezer
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.